FIRING SQUADS Return—Trump Administration Makes It Official

Soldiers executing a prisoner in a military setting

The Trump administration has reinstated firing squads as a federal execution method, marking a dramatic shift in capital punishment policy that critics say bypasses the very drug shortages created by government failures.

Story Snapshot

DOJ authorized firing squads on April 24, 2026, as backup federal execution method alongside reinstated pentobarbital lethal injection
Policy aims to overcome lethal injection drug shortages caused by European export restrictions and pharmaceutical company refusals
Trump’s Day One 2025 executive order set aggressive death penalty expansion targeting cop killers and crimes by illegal immigrants
Sixteen inmates currently await federal execution after five-year Biden-era moratorium that DOJ now criticizes as weakening justice

Trump Administration Revives Controversial Execution Methods

The Department of Justice announced Friday, April 24, 2026, the readoption of firing squads for federal executions, alongside the reinstatement of pentobarbital-based lethal injection protocols from President Trump’s first term. Acting Attorney General Todd Blanche characterized the move as “enforcing the law and standing with victims,” authorizing death sentences for nine individuals while streamlining execution processes. The policy also contemplates electrocution and lethal gas as additional alternatives, though firing squads serve as the primary backup when pentobarbital becomes unavailable through normal procurement channels.

Addressing Drug Shortages Through Alternative Methods

The reinstatement responds directly to persistent shortages of execution drugs created when European manufacturers and American pharmaceutical companies refused to supply substances for capital punishment. During Trump’s first term from 2017 to 2021, the federal government conducted 13 executions using single-drug pentobarbital lethal injection—more than any modern president—before Biden’s 2021 moratorium halted the practice. Several states have already adopted firing squads in recent years due to identical drug availability problems, with the Supreme Court historically upholding these methods as consistent with Eighth Amendment protections against cruel and unusual punishment.

Executive Action Drives Death Penalty Expansion

President Trump signed an executive order on his first day back in office, January 20, 2025, directing federal prosecutors to aggressively pursue death sentences for severe crimes including murders of law enforcement officers and capital offenses committed by undocumented immigrants. Then-Attorney General Pam Bondi lifted Biden’s execution moratorium in February 2025, immediately seeking death penalties in high-profile cases like the UnitedHealthcare CEO killing and MS-13 gang murders in California. The administration released a critical report slamming Biden-era policies for creating unnecessary delays and “weakening” capital punishment, positioning current leadership as restoring accountability that bureaucrats had systematically undermined for political reasons.

Implications for Federal Death Row and Justice System

Sixteen individuals currently reside on federal death row, all sentenced since 1976 and previously facing execution solely through lethal injection. The streamlined protocols promise expedited case processing and executions targeting the administration’s priority categories, potentially increasing federal death sentences significantly compared to the previous five-year pause. Victims’ families receive promised closure through swifter justice, while law enforcement gains enhanced protections through prioritized prosecutions. The policy establishes precedent for alternative execution methods at the federal level, addressing practical obstacles that have paralyzed capital punishment implementation while arguably demonstrating how government dysfunction—from drug procurement failures to ideological moratoria—has prevented elected leaders from fulfilling the people’s will on law and order.

The DOJ maintains the reinstated methods comply fully with constitutional requirements, citing legal precedents and proactive planning to overcome pharmaceutical industry resistance. Whether this signals genuine commitment to victims’ rights or merely political theater from an administration seeking tough-on-crime credentials remains a point of contention, but both conservatives frustrated with selective law enforcement and liberals concerned about government competence can agree on one reality: the execution drug shortage itself represents a policy failure where international pressure and corporate activism have effectively constrained democratically enacted criminal justice laws.